IFNG and rheumatoid arthritis: To avoid the proinflammatory effect of IFN‐γ, we proposed a novel biomimetic therapeutic strategy for RA by coating nanoparticles with cell membrane derived from regulatory FLS induced by IFN‐γ plus rapamycin, which we called FIRN.